Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
TLDR
The effects of PDK inhibition on the prevention of metabolic diseases using pharmacological inhibitors are described and PDK isoenzymes are strong therapeutic targets for preventing and treating metabolic diseases.Abstract:
Impaired glucose homeostasis is one of the risk factors for causing metabolic diseases including obesity, type 2 diabetes, and cancers. In glucose metabolism, pyruvate dehydrogenase complex (PDC) mediates a major regulatory step, an irreversible reaction of oxidative decarboxylation of pyruvate to acetyl-CoA. Tight control of PDC is critical because it plays a key role in glucose disposal. PDC activity is tightly regulated using phosphorylation by pyruvate dehydrogenase kinases (PDK1 to 4) and pyruvate dehydrogenase phosphatases (PDP1 and 2). PDKs and PDPs exhibit unique tissue expression patterns, kinetic properties, and sensitivities to regulatory molecules. During the last decades, the up-regulation of PDKs has been observed in the tissues of patients and mammals with metabolic diseases, which suggests that the inhibition of these kinases may have beneficial effects for treating metabolic diseases. This review summarizes the recent advances in the role of specific PDK isoenzymes on the induction of metabolic diseases and describes the effects of PDK inhibition on the prevention of metabolic diseases using pharmacological inhibitors. Based on these reports, PDK isoenzymes are strong therapeutic targets for preventing and treating metabolic diseases.read more
Citations
More filters
Journal ArticleDOI
Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis.
TL;DR: It is clear that plasticity in tumor metabolic programs, which allows cancer cells to adapt and grow in hostile microenvironments, is emerging as an important variable that may change clinical approaches to managing metastatic disease.
Journal ArticleDOI
Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
F. Peng,F. Peng,J. H. Wang,W. J. Fan,W. J. Fan,Y. T. Meng,Y. T. Meng,Miao Li,Miao Li,Tongtong Li,B. Cui,H. F. Wang,Y. Zhao,F. An,T. Guo,Xuefeng Liu,Li Zhang,L. Lv,Dekang Lv,Lele Xu,J. J. Xie,W. X. Lin,Eric Lam,Jie Xu,Qiang Liu +24 more
TL;DR: It is shown that pyruvate dehydrogenase kinase 1 (PDK1) is enriched in breast cancer stem cells (BCSCs), whereas depletion of PDK1 remarkably diminishes ALDH+ subpopulations, decreases stemness-related transcriptional factor expression, and inhibits sphere-formation ability and tumor growth.
Journal ArticleDOI
Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?
TL;DR: This review focuses on the pathological changes in metabolism, observed during sepsis, and the presumed underlying mechanisms, with a focus on the level of the organism and the interplay between different organ systems.
Journal ArticleDOI
Spatial Organization of Metabolic Enzyme Complexes in Cells
Danielle L. Schmitt,Songon An +1 more
TL;DR: The current understanding of metabolic enzyme complexes is discussed by primarily focusing on central carbon metabolism and closely associated metabolic pathways in a variety of organisms, as well as their regulation and functional contributions to cells.
Journal ArticleDOI
Molecular interactions underpinning the phenotype of hibernation in mammals.
TL;DR: Recent advances in the molecular biology of mammalian hibernation are covered, including the role of small molecules, seasonal changes in gene expression, cold-inducible RNA-binding proteins, the somatosensory system and emerging information on hibernating primates.
References
More filters
Journal ArticleDOI
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
Journal ArticleDOI
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
TL;DR: A hypoxia-induced metabolic switch that shunts glucose metabolites from the mitochondria to glycolysis to maintain ATP production and to prevent toxic ROS production is revealed.
Journal ArticleDOI
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
TL;DR: It is shown by genetic means that HIF-1-dependent block to oxygen utilization results in increased oxygen availability, decreased cell death when total oxygen is limiting, and reduced cell death in response to the hypoxic cytotoxin tirapazamine.
Journal ArticleDOI
Regulation of mammalian o2 homeostasis by hypoxia-inducible factor 1
TL;DR: HIF-1 appears to function as a master regulator of O2 homeostasis that plays essential roles in cellular and systemic physiology, development, and pathophysiology.
Journal ArticleDOI
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
Michael Ohh,Cheol Won Park,Cheol Won Park,Mircea Ivan,Michael A. Hoffman,Tae-You Kim,Tae-You Kim,L. Eric Huang,Nikola P. Pavletich,Nikola P. Pavletich,Vincent Chau,William G. Kaelin,William G. Kaelin +12 more
TL;DR: It is shown that pVHL, through its β-domain, binds directly to hypoxia-inducible factor (HIF), thereby targeting HIF for ubiquitination in an α-domain-dependent manner, the first function to be ascribed to the pV HL β- domain.